-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Alpha Teknova, Inc. (NASDAQ:TKNO) CEO Stephen Gunstream Acquires 18,000 Shares of Stock
Alpha Teknova, Inc. (NASDAQ:TKNO) CEO Stephen Gunstream Acquires 18,000 Shares of Stock
Alpha Teknova, Inc. (NASDAQ:TKNO – Get Rating) CEO Stephen Gunstream acquired 18,000 shares of the firm's stock in a transaction on Monday, August 15th. The stock was purchased at an average cost of $5.13 per share, with a total value of $92,340.00. Following the completion of the transaction, the chief executive officer now owns 18,000 shares in the company, valued at $92,340. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website.
Alpha Teknova Stock Performance
Shares of TKNO stock opened at $5.18 on Tuesday. The company has a debt-to-equity ratio of 0.13, a quick ratio of 6.10 and a current ratio of 6.77. Alpha Teknova, Inc. has a one year low of $4.23 and a one year high of $28.64. The company's 50-day simple moving average is $7.42 and its 200-day simple moving average is $11.27. The stock has a market capitalization of $145.12 million, a price-to-earnings ratio of -7.72 and a beta of -1.05.
Get Alpha Teknova alerts:Alpha Teknova (NASDAQ:TKNO – Get Rating) last issued its quarterly earnings results on Wednesday, August 10th. The company reported ($0.22) EPS for the quarter, topping the consensus estimate of ($0.25) by $0.03. Alpha Teknova had a negative net margin of 43.93% and a negative return on equity of 13.25%. During the same quarter in the previous year, the business earned ($0.52) EPS. Equities analysts anticipate that Alpha Teknova, Inc. will post -0.94 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
Separately, Stephens decreased their price objective on shares of Alpha Teknova from $22.00 to $15.00 and set an "overweight" rating for the company in a research report on Thursday, August 11th.Hedge Funds Weigh In On Alpha Teknova
Large investors have recently modified their holdings of the stock. Alpha Paradigm Partners LLC acquired a new stake in Alpha Teknova during the fourth quarter worth about $190,000. Parian Global Management LP acquired a new stake in Alpha Teknova during the fourth quarter worth about $780,000. Ranger Investment Management L.P. raised its stake in Alpha Teknova by 18.1% during the fourth quarter. Ranger Investment Management L.P. now owns 264,446 shares of the company's stock worth $5,416,000 after acquiring an additional 40,554 shares during the period. New York State Common Retirement Fund raised its stake in Alpha Teknova by 19.3% during the fourth quarter. New York State Common Retirement Fund now owns 35,019 shares of the company's stock worth $717,000 after acquiring an additional 5,657 shares during the period. Finally, State Board of Administration of Florida Retirement System acquired a new stake in Alpha Teknova during the second quarter worth about $129,000. Institutional investors own 25.51% of the company's stock.
Alpha Teknova Company Profile
(Get Rating)
Alpha Teknova, Inc provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.
Further Reading
- Get a free copy of the StockNews.com research report on Alpha Teknova (TKNO)
- 3 Blowout Earnings Reports That Could Mark Turning Points
- Skyworks Solutions Is Worth A Look At These Prices
- Will CrowdStrike Extend Its Streak Of Topping Earnings Views?
- 3 Stocks Set to Lead the Nasdaq Bull Market
- MarketBeat Podcast: ESG – Profitably Invest Your Values
Receive News & Ratings for Alpha Teknova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Teknova and related companies with MarketBeat.com's FREE daily email newsletter.
Alpha Teknova, Inc. (NASDAQ:TKNO – Get Rating) CEO Stephen Gunstream acquired 18,000 shares of the firm's stock in a transaction on Monday, August 15th. The stock was purchased at an average cost of $5.13 per share, with a total value of $92,340.00. Following the completion of the transaction, the chief executive officer now owns 18,000 shares in the company, valued at $92,340. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website.
阿爾法·特克諾瓦公司(納斯達克代碼:TKNO-GET Rating)首席執行官斯蒂芬·岡斯特雷姆在8月15日(星期一)的一次交易中收購了18,000股該公司股票。這隻股票是以每股5.13美元的平均價格購買的,總價值為92,340.00美元。交易完成後,首席執行官現在擁有該公司18,000股股份,價值92,340美元。這筆收購是在提交給美國證券交易委員會的一份文件中披露的,該文件可以在美國證券交易委員會的網站上看到。
Alpha Teknova Stock Performance
阿爾法·特克諾瓦股票表現
Shares of TKNO stock opened at $5.18 on Tuesday. The company has a debt-to-equity ratio of 0.13, a quick ratio of 6.10 and a current ratio of 6.77. Alpha Teknova, Inc. has a one year low of $4.23 and a one year high of $28.64. The company's 50-day simple moving average is $7.42 and its 200-day simple moving average is $11.27. The stock has a market capitalization of $145.12 million, a price-to-earnings ratio of -7.72 and a beta of -1.05.
週二,TKNO的股票開盤報5.18美元。該公司的負債權益比率為0.13,速動比率為6.10,流動比率為6.77。Alpha Tenowva,Inc.的一年低點為4.23美元,一年高位為28.64美元。該公司的50日簡單移動均線切入位在7.42美元,200日簡單移動均線切入位在11.27美元。該股市值為1.4512億美元,市盈率為-7.72,貝塔係數為-1.05。
Alpha Teknova (NASDAQ:TKNO – Get Rating) last issued its quarterly earnings results on Wednesday, August 10th. The company reported ($0.22) EPS for the quarter, topping the consensus estimate of ($0.25) by $0.03. Alpha Teknova had a negative net margin of 43.93% and a negative return on equity of 13.25%. During the same quarter in the previous year, the business earned ($0.52) EPS. Equities analysts anticipate that Alpha Teknova, Inc. will post -0.94 earnings per share for the current fiscal year.
阿爾法·泰克諾瓦(納斯達克代碼:TKNO-GET Rating)上一次發佈季度收益報告是在8月10日星期三。該公司公佈本季度每股收益(0.22美元),比普遍預期的(0.25美元)高出0.03美元。阿爾法·特克諾瓦的淨利潤率為負43.93%,股本回報率為負13.25%。在去年同一季度,該業務實現每股收益(0.52美元)。股票分析師預計,阿爾法·特克諾瓦公司本財年的每股收益將達到0.94美元。
Wall Street Analysts Forecast Growth
華爾街分析師預測經濟增長
Hedge Funds Weigh In On Alpha Teknova
對衝基金對阿爾法·特克諾瓦的看法
Large investors have recently modified their holdings of the stock. Alpha Paradigm Partners LLC acquired a new stake in Alpha Teknova during the fourth quarter worth about $190,000. Parian Global Management LP acquired a new stake in Alpha Teknova during the fourth quarter worth about $780,000. Ranger Investment Management L.P. raised its stake in Alpha Teknova by 18.1% during the fourth quarter. Ranger Investment Management L.P. now owns 264,446 shares of the company's stock worth $5,416,000 after acquiring an additional 40,554 shares during the period. New York State Common Retirement Fund raised its stake in Alpha Teknova by 19.3% during the fourth quarter. New York State Common Retirement Fund now owns 35,019 shares of the company's stock worth $717,000 after acquiring an additional 5,657 shares during the period. Finally, State Board of Administration of Florida Retirement System acquired a new stake in Alpha Teknova during the second quarter worth about $129,000. Institutional investors own 25.51% of the company's stock.
大型投資者最近調整了對該股的持有量。Alpha Paradigm Partners LLC在第四季度收購了Alpha Tenowva的新股份,價值約19萬美元。帕裏安全球管理有限公司在第四季度收購了阿爾法·特克諾瓦的新股份,價值約78萬美元。Ranger Investment Management L.P.在第四季度將其在Alpha Tenowva的持股增加了18.1%。Ranger Investment Management L.P.在此期間增持了40,554股,現在擁有264,446股該公司股票,價值5,416,000美元。紐約州共同退休基金在第四季度將其在Alpha Tenowva的持股增加了19.3%。紐約州共同退休基金現在擁有35,019股該公司的股票,價值717,000美元,在此期間又購買了5,657股。最後,佛羅裏達州退休系統管理委員會在第二季度收購了阿爾法·特克諾瓦的新股份,價值約12.9萬美元。機構投資者持有該公司25.51%的股票。
Alpha Teknova Company Profile
阿爾法·特克諾瓦公司簡介
(Get Rating)
(獲取評級)
Alpha Teknova, Inc provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.
阿爾法·特諾瓦公司為美國和國際生命科學市場提供關鍵試劑。它的試劑使生物製藥產品的發現、開發和生產成為可能,如藥物療法、新型疫苗和分子診斷。該公司提供用於細胞生長和克隆的預先澆注的培養基板;用於細胞擴增的液體細胞培養液和補充劑;以及用於樣品處理、再懸浮和純化的分子生物試劑。
Further Reading
進一步閲讀
- Get a free copy of the StockNews.com research report on Alpha Teknova (TKNO)
- 3 Blowout Earnings Reports That Could Mark Turning Points
- Skyworks Solutions Is Worth A Look At These Prices
- Will CrowdStrike Extend Its Streak Of Topping Earnings Views?
- 3 Stocks Set to Lead the Nasdaq Bull Market
- MarketBeat Podcast: ESG – Profitably Invest Your Values
- 免費獲取StockNews.com關於阿爾法·特克諾瓦的研究報告(TKNO)
- 3份井噴式收益報告可能標誌着轉折點
- Skyworks Solutions值得看看這些價格
- CrowdStrike是否會延續其盈利排行榜榜首的勢頭?
- 3只股票將引領納斯達克牛市
- MarketBeat播客:ESG--有利可圖地投資你的價值
Receive News & Ratings for Alpha Teknova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Teknova and related companies with MarketBeat.com's FREE daily email newsletter.
接收阿爾法·特克諾瓦日報的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Alpha Tenowva和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧